<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9">
 <label>9.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Bersanelli</surname>
    <given-names>M</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Giannarelli</surname>
    <given-names>D</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Castrignanò</surname>
    <given-names>P</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>INfluenza vaccine indication during therapy with immune checkpoint inhibitors: a transversal challenge. The INVIDIa study</article-title>. 
  <source>Immunotherapy.</source>
  <volume>10</volume>(
  <issue>14</issue>), 
  <fpage>1229</fpage>–
  <lpage>1239</lpage> (
  <year>2018</year>).
  <pub-id pub-id-type="pmid">30326787</pub-id>
 </mixed-citation>
</ref>
